ARISTADA (ARIPIPRAZOLE LAUROXIL)
ARISTADA (ARIPIPRAZOLE LAUROXIL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ARISTADA; Generic name: ARIPIPRAZOLE LAUROXIL; Manufacturer: Alkermes, Inc..
| Brand name | ARISTADA |
|---|---|
| Generic name | ARIPIPRAZOLE LAUROXIL |
| Manufacturer | Alkermes, Inc. |
| Used for | 1 INDICATIONS AND USAGE ARISTADA is indicated for the treatment of schizophrenia in adults [see Clinical Studies ( 14 )]. ARISTADA is an atypical antipsychotic indicated for the treatment of schizophrenia in adults ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administer ARISTADA by intramuscular injection in the deltoid (441 mg dose only) or gluteal (441 mg, 662 mg, 882 mg or 1064 mg) muscle by a healthcare professional ( 2.1 ). For patients naïve to aripiprazole, establish tolerability with oral aripiprazole prior to initiating treatment with ARISTADA ( 2.1 ). There are two options for initiating treatment with ARISTADA: Option #1: Administer one injection of 675 mg of ARISTADA INITIO ® and one 30 mg dose of oral aripipra |
| Warnings | WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. ARISTADA is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions ( 5.1 )] . WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS See full prescribing information for complete boxed warning. Elderly patients with dementia-r |
| Active ingredient(s) | ARIPIPRAZOLE LAUROXIL |
| Route | INTRAMUSCULAR |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17a8d11b-73b0-4833-a0b4-cf1ef85edefb |